Embecta Corp. (EMBC)
Market Cap | 1.57B |
Revenue (ttm) | 1.13B |
Net Income (ttm) | 223.60M |
Shares Out | 57.21M |
EPS (ttm) | 3.89 |
PE Ratio | 7.03 |
Forward PE | n/a |
Dividend | $0.30 (1.10%) |
Ex-Dividend Date | Aug 25, 2022 |
Volume | 568,493 |
Open | 26.34 |
Previous Close | 26.39 |
Day's Range | 25.69 - 27.68 |
52-Week Range | 22.30 - 49.00 |
Beta | n/a |
Analysts | Sell |
Price Target | 27.03 (-1.21%) |
Earnings Date | Feb 14, 2023 |
About EMBC
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, ... [Read more]
Full Company ProfileFinancial Performance
In 2022, Embecta's revenue was $1.13 billion, a decrease of -3.07% compared to the previous year's $1.17 billion. Earnings were $223.60 million, a decrease of -46.09%.
Financial StatementsAnalyst Forecast
According to 8 analysts, the average rating for EMBC stock is "Sell." The 12-month stock price forecast is $27.03, which is a decrease of -1.21% from the latest price.
News

embecta opens new global headquarters in Parsippany, N.J.
PARSIPPANY, N.J., Jan. 25, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world following its April 1, 2022, spinoff fro...

embecta to Report Fiscal First Quarter 2023 Financial Results
PARSIPPANY, N.J., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, will host a conference call to discuss ...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Embecta Corp. - EMBC
NEW YORK , Jan. 19, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Embecta Corp. ("Embecta" or the "Company") (NASDAQ: EMBC). Such investors are advised to contac...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Embecta Corp. - EMBC
New York, New York--(Newsfile Corp. - January 7, 2023) - Pomerantz LLP is investigating claims on behalf of investors of Embecta Corp. ("Embecta" or the "Company") (NASDAQ: EMBC). Such investors are a...

INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Embecta Corp. and Encourages Investors with Losses to Contact the Firm
Los Angeles, California--(Newsfile Corp. - January 6, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Em...

EMBECTA ALERT: Bragar Eagel & Squire, P.C. is Investigating Embecta Corp. on Behalf of Embecta Stockholders and Encourages Investors to Contact the Firm
NEW YORK--(BUSINESS WIRE)--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Embecta Corp. (“Embecta” or the “Company”) (NAS...

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Embecta Corp. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Embecta Corp. (“Embecta” or “the...

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Embecta Corp. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Embecta Corp. (“Embecta” or “the...

Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against Embecta Corp. (EMBC)
NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against Embecta Corporation (“Embecta” or the “Company”) (NASDAQ: EMBC). The investigation concerns w...

Embecta Corp. Reports Fiscal 2022 Fourth Quarter and Full Year Financial Results
PARSIPPANY, N.J., Dec. 20, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, today reported financial results for th...

embecta Announces Quarterly Cash Dividend
PARSIPPANY, N.J., Dec. 20, 2022 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (NASDAQ: EMBC) have declared a quarterly cash dividend of $0.15 for each issued and outstanding ...

embecta to Participate at the 41st Annual J.P. Morgan Healthcare Conference
PARSIPPANY, N.J., Dec. 14, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will present at the J.P. Morgan Healthcare Conference in San Francisco on Wed...

Intuity Medical and embecta Launch Commercial Collaboration, Expanding Access to Self-Management Innovations for People With Diabetes
FREMONT, Calif. and PARSIPPANY, N.J., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Intuity Medical, Inc. and Embecta Corp. (“embecta”) (NASDAQ: EMBC) today announced they have signed a co-promotional agreement u...

embecta to Report Fiscal 2022 Fourth Quarter and Full Year Financial Results
PARSIPPANY, N.J., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, will host a conference call to discuss ...

embecta to Recognize National Diabetes Awareness Month by Ringing Nasdaq Opening Bell
Advocacy and professional groups including Beyond Type 1, Beyond Type 2, Camp Nejeda, Children with Diabetes, DiabetesSisters, diaTribe Foundation, The Diabetes Foundation, The Diabetes Link and ADCES...

3 Hidden Gem Stock Picks to Beat the September Market Slump
These days the most popular stocks to follow are either meme plays or the most blue-chip S&P 500 companies. Very few investors seem to be interested in hidden gem stock picks.

embecta to Participate in Upcoming Investor Conferences in September
PARSIPPANY, N.J., Aug. 18, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will participate in the following upcoming investor conferences:

Embecta Corp. Reports Third Quarter Fiscal 2022 Financial Results
PARSIPPANY, N.J., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world following its April 1, 2022, spin off fr...

embecta Announces Inaugural Quarterly Cash Dividend
PARSIPPANY, N.J., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (NASDAQ: EMBC), one of the largest pure-play diabetes care companies, announced today that its Board of Directors declared...

embecta Announces Earnings Conference Call Information for the Third Quarter of Fiscal Year 2022
PARSIPPANY, N.J., July 05, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (NASDAQ: EMBC), one of the largest pure-play diabetes care companies in the world following its April 1, 2022, spin off fr...

Spinoffs Roundup: These Companies Could Unlock Value in 2022
Spinoffs are known for being a mixed bag from the investor's viewpoint. Some of them can unlock the true value of businesses by allowing them to focus on their niches rather than being hampered by und...

Why Embecta Shares Are Falling Today
Becton Dickinson and Co's (NYSE: BDX) pure-play diabetes spin-off Embecta Corp (NASDAQ: EMBC) has reported Q2 sales of $274.5 million, down 3.4% on a reported basis, down 1.3% on a constant currency b...

Embecta Corp. Reports Second Quarter and First Six Months of Fiscal Year 2022 Financial Results and Provides Financial Guidance for the Last Six Months of Fiscal Year 2022
PARSIPPANY, N.J., May 13, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world following its April 1, 2022, spin off fro...

embecta Announces Second Quarter 2022 Earnings Conference Call Information
FRANKLIN LAKES, N.J., April 19, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (NASDAQ: EMBC) today announced that it will report its financial results for the second quarter of fiscal year 2022 bef...

Becton Dickinson Spinoff Embecta Is a Stock to Watch
Embecta Corp. ( EMBC , Financial) may be new to the public markets, but it is well-established in the diabetes field and now free from the control of Becton, Dickinson and Co. ( BDX , Financial) to im...